The COMPARZ results complement the PISCES data – continued 1 Patients (%) 90% CI (for difference): 37.0%-61.5%; p<0.001 70% (n=80) 22% (n=25) 8% (n=9)
{"Image DocumentName": "The COMPARZ results complement the PISCES data \u2013 continued1", "Image ImageDescription": "Patients (%) 90% CI (for difference): 37.0%-61.5%; p< % (n=80) 22% (n=25) 8% (n=9)  Question asked: Now that you have completed both treatments, which of the two drugs would you prefer to continue to take as the treatment for your cancer, assuming that both drugs will work equally well in treating your cancer? (patients selected either first treatment, second treatment or no preference) 1. Escudier BJ, Porta C, Bono P, et al. Abstract and oral presentation at the American Society of Clinical Oncology Annual Congress J Clin Oncol 2012; 30 (suppl.): Abstract CRA4502.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}